Literature DB >> 24145445

Regulation of IL-1β-induced NF-κB by hydroxylases links key hypoxic and inflammatory signaling pathways.

Carsten C Scholz1, Miguel A S Cavadas, Murtaza M Tambuwala, Emily Hams, Javier Rodríguez, Alex von Kriegsheim, Philip Cotter, Ulrike Bruning, Padraic G Fallon, Alex Cheong, Eoin P Cummins, Cormac T Taylor.   

Abstract

Hypoxia is a prominent feature of chronically inflamed tissues. Oxygen-sensing hydroxylases control transcriptional adaptation to hypoxia through the regulation of hypoxia-inducible factor (HIF) and nuclear factor κB (NF-κB), both of which can regulate the inflammatory response. Furthermore, pharmacologic hydroxylase inhibitors reduce inflammation in multiple animal models. However, the underlying mechanism(s) linking hydroxylase activity to inflammatory signaling remains unclear. IL-1β, a major proinflammatory cytokine that regulates NF-κB, is associated with multiple inflammatory pathologies. We demonstrate that a combination of prolyl hydroxylase 1 and factor inhibiting HIF hydroxylase isoforms regulates IL-1β-induced NF-κB at the level of (or downstream of) the tumor necrosis factor receptor-associated factor 6 complex. Multiple proteins of the distal IL-1β-signaling pathway are subject to hydroxylation and form complexes with either prolyl hydroxylase 1 or factor inhibiting HIF. Thus, we hypothesize that hydroxylases regulate IL-1β signaling and subsequent inflammatory gene expression. Furthermore, hydroxylase inhibition represents a unique approach to the inhibition of IL-1β-dependent inflammatory signaling.

Entities:  

Keywords:  OTUB1; UBC13; inflammatory disease; oxygen

Mesh:

Substances:

Year:  2013        PMID: 24145445      PMCID: PMC3832034          DOI: 10.1073/pnas.1309718110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  HIF-1alpha is essential for myeloid cell-mediated inflammation.

Authors:  Thorsten Cramer; Yuji Yamanishi; Björn E Clausen; Irmgard Förster; Rafal Pawlinski; Nigel Mackman; Volker H Haase; Rudolf Jaenisch; Maripat Corr; Victor Nizet; Gary S Firestein; Hans Peter Gerber; Napoleone Ferrara; Randall S Johnson
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

2.  Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity.

Authors:  Eoin P Cummins; Edurne Berra; Katrina M Comerford; Amandine Ginouves; Kathleen T Fitzgerald; Fergal Seeballuck; Catherine Godson; Jens E Nielsen; Paul Moynagh; Jacques Pouyssegur; Cormac T Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

Review 3.  A clinical perspective of IL-1β as the gatekeeper of inflammation.

Authors:  Charles A Dinarello
Journal:  Eur J Immunol       Date:  2011-05       Impact factor: 5.532

4.  The proinflammatory cytokine interleukin 1beta and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation.

Authors:  Stilla Frede; Patricia Freitag; Teresa Otto; Christina Heilmaier; Joachim Fandrey
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

5.  Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor.

Authors:  Terrance D Barrett; Heather L Palomino; Theresa I Brondstetter; Kimon C Kanelakis; Xiaodong Wu; Peter V Haug; Wen Yan; Andrew Young; Hong Hua; Juliet C Hart; Da-Thao Tran; Hariharan Venkatesan; Mark D Rosen; Hillary M Peltier; Kia Sepassi; Michele C Rizzolio; Scott D Bembenek; Tara Mirzadegan; Michael H Rabinowitz; Nigel P Shankley
Journal:  Mol Pharmacol       Date:  2011-03-03       Impact factor: 4.436

6.  An intact canonical NF-κB pathway is required for inflammatory gene expression in response to hypoxia.

Authors:  Susan F Fitzpatrick; Murtaza M Tambuwala; Ulrike Bruning; Bettina Schaible; Carsten C Scholz; Annette Byrne; Aisling O'Connor; William M Gallagher; Colin R Lenihan; John F Garvey; Katherine Howell; Padraic G Fallon; Eoin P Cummins; Cormac T Taylor
Journal:  J Immunol       Date:  2010-12-13       Impact factor: 5.422

Review 7.  Hypoxia and inflammation.

Authors:  Holger K Eltzschig; Peter Carmeliet
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

8.  Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH).

Authors:  Matthew E Cockman; David E Lancaster; Ineke P Stolze; Kirsty S Hewitson; Michael A McDonough; Mathew L Coleman; Charlotte H Coles; Xiaohong Yu; Ronald T Hay; Steven C Ley; Christopher W Pugh; Neil J Oldham; Norma Masson; Christopher J Schofield; Peter J Ratcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

9.  Factor-inhibiting hypoxia-inducible factor (FIH) catalyses the post-translational hydroxylation of histidinyl residues within ankyrin repeat domains.

Authors:  Ming Yang; Rasheduzzaman Chowdhury; Wei Ge; Refaat B Hamed; Michael A McDonough; Timothy D W Claridge; Benedikt M Kessler; Matthew E Cockman; Peter J Ratcliffe; Christopher J Schofield
Journal:  FEBS J       Date:  2011-02-23       Impact factor: 5.542

10.  Asparagine and aspartate hydroxylation of the cytoskeletal ankyrin family is catalyzed by factor-inhibiting hypoxia-inducible factor.

Authors:  Ming Yang; Wei Ge; Rasheduzzaman Chowdhury; Timothy D W Claridge; Holger B Kramer; Bernhard Schmierer; Michael A McDonough; Lingzhi Gong; Benedikt M Kessler; Peter J Ratcliffe; Mathew L Coleman; Christopher J Schofield
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

View more
  68 in total

1.  Venous thrombosis at altitude presents with distinct biochemical profiles: a comparative study from the Himalayas to the plains.

Authors:  Amit Prabhakar; Tathagata Chatterjee; Nitin Bajaj; Tarun Tyagi; Anita Sahu; Neha Gupta; Babita Kumari; Velu Nair; Bhuvnesh Kumar; Mohammad Zahid Ashraf
Journal:  Blood Adv       Date:  2019-11-26

2.  Hypoxia and inflammation are two sides of the same coin.

Authors:  Karsten Bartels; Almut Grenz; Holger K Eltzschig
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-01       Impact factor: 11.205

Review 3.  Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer.

Authors:  Matthew Saldana; Kacey VanderVorst; Anastasia L Berg; Hyun Lee; Kermit L Carraway
Journal:  Endocr Relat Cancer       Date:  2019-01-01       Impact factor: 5.678

4.  The Prolyl Hydroxylase Inhibitor Dimethyl Oxalyl Glycine Decreases Early Gastrointestinal GVHD in Experimental Allogeneic Hematopoietic Cell Transplantation.

Authors:  Senthilnathan Palaniyandi; Reena Kumari; Sabarinath Venniyil Radhakrishnan; Ethan Strattan; Natalya Hakim; Reinhold Munker; Melissa V Kesler; Gerhard C Hildebrandt
Journal:  Transplantation       Date:  2020-12       Impact factor: 4.939

Review 5.  Emerging co-morbidities of obstructive sleep apnea: cognition, kidney disease, and cancer.

Authors:  Nadia Gildeh; Panagis Drakatos; Sean Higgins; Ivana Rosenzweig; Brian D Kent
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 6.  New Insights into Protein Hydroxylation and Its Important Role in Human Diseases.

Authors:  Giada Zurlo; Jianping Guo; Mamoru Takada; Wenyi Wei; Qing Zhang
Journal:  Biochim Biophys Acta       Date:  2016-09-20

Review 7.  Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Rémy Guillevin; Yves Lecarpentier
Journal:  Cell Mol Neurobiol       Date:  2017-09-13       Impact factor: 5.046

Review 8.  HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.

Authors:  Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

Review 9.  Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD.

Authors:  Sophie Van Welden; Andrew C Selfridge; Pieter Hindryckx
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-30       Impact factor: 46.802

Review 10.  Hypoxia-dependent regulation of inflammatory pathways in immune cells.

Authors:  Cormac T Taylor; Glen Doherty; Padraic G Fallon; Eoin P Cummins
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.